Novo Nordisk a/S Product Market 2016 Size, Share, Trends and Forecast 2016
- Submitted by: rickybill
- Views: 68
- Category: Other
- Date Submitted: 04/25/2016 12:12 AM
- Pages: 2
- Report this Essay
Novo Nordisk A/S Product Market Outlook, Business Overview and Analysis, Research and Development, Pipeline Review 2016
Global Markets Direct's, 'Novo Nordisk A/S - Product Pipeline Review - 2016', provides an overview of the Novo Nordisk A/S's pharmaceutical research and development focus.
The report provides comprehensive information on the therapeutics under development by Novo Nordisk A/S, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.
Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.
Browse Detail Report With TOC @ http://www.radiantinsights.com/research/novo-nordisk-a-s-product-pipeline-review-2016
Scope
The report provides a snapshot of the pipeline therapeutic landscape of Novo Nordisk A/S
The report provides overview of Novo Nordisk A/S including its business description, key facts, and locations and subsidiaries
Table Of Content
Table of Contents 2
List of Tables 6
Buy a Sample copy of This Report @ http://www.radiantinsights.com/checkout/167943
List of Figures 6
Novo Nordisk A/S Snapshot 7
Novo Nordisk A/S Overview 7
Key Information 7
Key Facts 7
Novo Nordisk A/S - Research and Development Overview 8
Key Therapeutic Areas 8
Novo Nordisk A/S - Pipeline Review 11
Pipeline Products by Stage of Development 11
Pipeline Products - Monotherapy 12
Pipeline Products -...
Global Markets Direct's, 'Novo Nordisk A/S - Product Pipeline Review - 2016', provides an overview of the Novo Nordisk A/S's pharmaceutical research and development focus.
The report provides comprehensive information on the therapeutics under development by Novo Nordisk A/S, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.
Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.
Browse Detail Report With TOC @ http://www.radiantinsights.com/research/novo-nordisk-a-s-product-pipeline-review-2016
Scope
The report provides a snapshot of the pipeline therapeutic landscape of Novo Nordisk A/S
The report provides overview of Novo Nordisk A/S including its business description, key facts, and locations and subsidiaries
Table Of Content
Table of Contents 2
List of Tables 6
Buy a Sample copy of This Report @ http://www.radiantinsights.com/checkout/167943
List of Figures 6
Novo Nordisk A/S Snapshot 7
Novo Nordisk A/S Overview 7
Key Information 7
Key Facts 7
Novo Nordisk A/S - Research and Development Overview 8
Key Therapeutic Areas 8
Novo Nordisk A/S - Pipeline Review 11
Pipeline Products by Stage of Development 11
Pipeline Products - Monotherapy 12
Pipeline Products -...